Archimedes Pharma UK Ltd

250 South Oak Way, Green Park, Reading, RG2 6UG, UK
Telephone: +44 (0)118 931 5050
Fax: +44 (0)118 931 5056
WWW: http://www.archimedespharma.com

Summary of Product Characteristics last updated on the eMC: 03/01/2012
SPC Sytron

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to section 6. 3 - Shelf Life
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   01-Mar-2011
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company


  • In section 6.3 (shelf life) the shelf life has changed from 60 months to 36 months
  • In Section 10 the date of revision of the text has changed to March 2011
Updated on 11/06/2008 and displayed until 03/01/2012
Reasons for adding or updating:
  • Change of Marketing Authorisation Holder
Date of revision of text on the SPC:   01-Nov-2007
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

In section 7 the Marketing Authorisation Holder name has changed to Archimedes Pharma Limited, 250 South Oak Way, Green Park, Reading, Berkshire, RG2 6UG, UK
Updated on 06/03/2007 and displayed until 11/06/2008
Reasons for adding or updating:
  • Change to section 6. 3 - Shelf Life
Date of revision of text on the SPC:   06/2006
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Update to in-use shelf life.
Updated on 13/02/2006 and displayed until 06/03/2007
Reasons for adding or updating:
  • Change to section 6. 5 - Nature and Contents of Container
Updated on 05/05/2004 and displayed until 13/02/2006
Reasons for adding or updating:
  • Change to section 4.1 - Therapeutic Indications
  • Change to section 9 - Date of Renewal of Authorisation
Updated on 21/08/2001 and displayed until 05/05/2004
Reasons for adding or updating:
  • Change to section 2 - qualitative and quantitative composition
  • Change to section 7 - Marketing Authorisation Holder
Updated on 06/09/1999 and displayed until 21/08/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   sodium feredetate